• Clinical Evidence

Successful Utilization of a Computer-Guided Glucose Management System for a Surgical Care Improvement Project at a Tertiary Care Hospital

Setting: 950-bed tertiary care teaching hospital

Objective

This surgical care improvement project examines the correlation between utilization of a computer-guided glucose management system (EndoTool) and outcomes of national quality initiatives.

Setting

950-bed tertiary care teaching hospital.

Results

  • Over a period of four years and 8,078 patients, average time to target blood glucose was 3.38 hours for 180 mg/dL, 3.99 hours for 160 mg/dL, 4.51 hours for 150 mg/dL and 5.35 hours for 140 mg/dL.
  • Over a period of four years and and 260,870 blood glucose readings, incidence of hypoglycemia <40 mg/dL was 0.02% and <70 mg/dL was 0.86%.
  • Rate of hospital-acquired conditions per 1,000 under HAC-8 (manifestations of poor glycemic control) decreased 61%, from 0.083 pre-EndoTool utilization to 0.032 post-EndoTool utilization, and was sustained at 45% lower than the national average of 0.058.
  • Rate of SCIP-Inf-4 compliance (glucose control for cardiac surgery patients) increased 12.5%, from 88% pre-EndoTool utilization to 99% post-EndoTool utilization.

Conclusions

Performance under the HAC-8 and SCIP-Inf-4 measures improve demonstrably in conjunction with use of a computer-guided glucose management system (EndoTool), representing a doubling in cost savings, with outcomes in the top tier of all hospitals nationwide.
Objective

This surgical care improvement project examines the correlation between utilization of a computer-guided glucose management system (EndoTool) and outcomes of national quality initiatives.

Setting

950-bed tertiary care teaching hospital.

Results
  • Over a period of four years and 8,078 patients, average time to target blood glucose was 3.38 hours for 180 mg/dL, 3.99 hours for 160 mg/dL, 4.51 hours for 150 mg/dL and 5.35 hours for 140 mg/dL.
  • Over a period of four years and and 260,870 blood glucose readings, incidence of hypoglycemia <40 mg/dL was 0.02% and <70 mg/dL was 0.86%.
  • Rate of hospital-acquired conditions per 1,000 under HAC-8 (manifestations of poor glycemic control) decreased 61%, from 0.083 pre-EndoTool utilization to 0.032 post-EndoTool utilization, and was sustained at 45% lower than the national average of 0.058.
  • Rate of SCIP-Inf-4 compliance (glucose control for cardiac surgery patients) increased 12.5%, from 88% pre-EndoTool utilization to 99% post-EndoTool utilization.
Conclusions

Performance under the HAC-8 and SCIP-Inf-4 measures improve demonstrably in conjunction with use of a computer-guided glucose management system (EndoTool), representing a doubling in cost savings, with outcomes in the top tier of all hospitals nationwide.

References

Authors

Robert Tanenberg, MD; Sandra Hardee, PharmD; Herbert Garrison, MD; Joseph Elbeery, MD.

Source

Presented at American Diabetes Association Scientific Sessions.

Year

2013

Quick navigation
Objective
Setting
Results
Conclusions
References
Objective

This surgical care improvement project examines the correlation between utilization of a computer-guided glucose management system (EndoTool) and outcomes of national quality initiatives.

Setting

950-bed tertiary care teaching hospital.

Results
  • Over a period of four years and 8,078 patients, average time to target blood glucose was 3.38 hours for 180 mg/dL, 3.99 hours for 160 mg/dL, 4.51 hours for 150 mg/dL and 5.35 hours for 140 mg/dL.
  • Over a period of four years and and 260,870 blood glucose readings, incidence of hypoglycemia <40 mg/dL was 0.02% and <70 mg/dL was 0.86%.
  • Rate of hospital-acquired conditions per 1,000 under HAC-8 (manifestations of poor glycemic control) decreased 61%, from 0.083 pre-EndoTool utilization to 0.032 post-EndoTool utilization, and was sustained at 45% lower than the national average of 0.058.
  • Rate of SCIP-Inf-4 compliance (glucose control for cardiac surgery patients) increased 12.5%, from 88% pre-EndoTool utilization to 99% post-EndoTool utilization.
Conclusions

Performance under the HAC-8 and SCIP-Inf-4 measures improve demonstrably in conjunction with use of a computer-guided glucose management system (EndoTool), representing a doubling in cost savings, with outcomes in the top tier of all hospitals nationwide.

References

Authors

Robert Tanenberg, MD; Sandra Hardee, PharmD; Herbert Garrison, MD; Joseph Elbeery, MD.

Source

Presented at American Diabetes Association Scientific Sessions.

Year

2013

Short and Sweet Headlines are Best!

Related posts

Image
  • Clinical Evidence

Near Elimination of Severe Hypoglycemia with EndoTool IV Across a 19-Hospital Health System

Near Elimination of Severe Hypoglycemia with EndoTool IV Across a 19-Hospital Health System

To evaluate the impact of EndoTool IV insulin dosing software on reducing severe hypoglycemia (SH) (blood glucose < 40 mg/dL) across 19-hospitals at a prominent health system, including outcomes in patients with renal insufficiency.
Image
  • Clinical Evidence

Temple Health Achieves Zero Severe Hypoglycemia in Renally Impaired Patients with EndoTool SubQ

Temple Health Achieves Zero Severe Hypoglycemia in Renally Impaired Patients with EndoTool SubQ

To evaluate the safety and efficacy of the EndoTool SubQ (ETSQ) insulin dosing application for subcutaneous (SQ) insulin administration in hospitalized patients, and to compare clinical outcomes against those treated using a standard insulin order set. The analysis also examined performance in high-risk patients with advanced renal impairment.
Image
  • Clinical Evidence

Improving Inpatient Glycemic Safety at Temple Health with EndoTool SubQ

Improving Inpatient Glycemic Safety at Temple Health with EndoTool SubQ

Temple Health, a 3-hospital academic system was experiencing high rates of hypoglycemia due to reliance on sliding scale insulin (SSI). To improve safety and align with ADA guidelines, the hospital implemented EndoTool SubQ, a patient-specific insulin dosing software the supports four dosing protocols, including basal-bolus-correction (BBC).
Get in Touch

Ready to get started?

Fill in your details and one of our friendly team members will be in touch to show you how easily EndoTool can support your hospital.

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Name*
By submitting this form, you consent to the processing of your personal information, including sensitive personal information you provide, in accordance with the Monarch Medical Technologies Privacy Notice.